Gastrointestinal endocrine tumours. Glucagonomas
1Department of Endocrinology, Hammersmith Hospitals NHS Trust, London, UK.
Bailliere'S Clinical Gastroenterology
|December 1, 1996
Summary
Glucagonoma, a rare but treatable cancer, can achieve long-term survival through surgery, embolization, and somatostatin analogues. Early assessment at specialized centers improves clinical management for this challenging disease.
Area of Science:
- Endocrinology
- Oncology
- Surgical Oncology
Background:
- Glucagonoma is a rare neuroendocrine tumor with diverse clinical presentations.
- Despite its predominantly malignant nature, glucagonoma is treatable.
- Effective management requires a multidisciplinary approach and specialized care.
Purpose of the Study:
- To review the long-term outcomes of glucagonoma patients.
- To identify key factors contributing to prolonged symptom-free survival.
- To provide insights into the clinical management of glucagonoma.
Main Methods:
- Retrospective analysis of 18 patients with glucagonoma.
- Long-term follow-up over a 25-year period.
- Evaluation of treatment strategies including surgery, hepatic artery embolization, and somatostatin analogues.
Main Results:
- Prolonged symptom-free survival is achievable in glucagonoma patients.
- A combination of surgery, embolization, and somatostatin analogues is effective.
- Tertiary referral center assessment may improve outcomes.
Conclusions:
- Glucagonoma management is challenging but treatable.
- Multimodal therapy can lead to prolonged survival.
- Experience from specialized centers offers valuable lessons for clinical practice.
More Related Videos
07:00Mechanisms Underlying Gut Hormone Secretion Using the Isolated Perfused Rat Small Intestine
Published on: February 26, 2019
10.0K
09:16Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells
Published on: April 20, 2017
16.1K
Related Concept Videos
01:15Hypoglycemia and Glucagon
839
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
839
01:24Glucagon-like Receptor Agonists
854
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
854
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.2K
01:16Cells and Secretions of the Pancreas
4.4K
The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
4.4K
01:29The Endocrine System
1.3K
The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that...
1.3K
01:16Hormones Regulating Blood Glucose
6.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.5K